The company, founded by UC Berkeley scientists including Jennifer Doudna, is preparing to test its lead candidate STX-1150 in ...

Growth is fuelled by increasing demand for advanced intracellular delivery solutions across gene therapy, oncology, and ...

Adoptive cell therapies (ACT) have become a transformative force in cancer immunology, offering powerful platforms for targeting both hematological and ...

Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal resistance in under 40 minutes. The assay provides rapid, precise results from ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Extinction has always been final — until now. Advances in genome sequencing, cloning, and genetic engineering have given ...

Any molecular biologist will tell you that genetic engineering is tricky. But up until recently we might be witnessing a new age in human development. Hosted by: Michael Aranda Dooblydoo thanks go to ...

The "Genetic Engineering Tool Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been ...

Genome Editing Market Genome Editing Market Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Global ...

Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

As genetic engineering technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) improve and ...